Sign inJoin waitlistJoin the waitlist

Stephen Lai

III Associate Leader · University of Texas M D Anderson Cancer Center

Credentials: · · · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

University of Pittsburgh
2003–2005
University of Pittsburgh
1998–2005
Otolaryngology – Head and Neck Surgery
University of Pennsylvania
1998–1999
University of California, San Francisco School of Medicine
1994–1998
Stanford University
1990–1994

Research

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Nature Medicine · 2018 · 705 citations
Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes
Nature Biotechnology · 2021 · 704 citations
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Systematic review or meta-analysis · JAMA · 2008 · 541 citations

Clifton Fuller
129 papers · 11 as a fellow
Katherine Hutcheson
80 papers
AM
Abdallah Mohamed
76 papers
Brandon Gunn
57 papers
David Rosenthal
46 papers
Adam Garden
43 papers
Mark Zafereo
35 papers
Vlad Sandulache
35 papers · 9 as a resident
Steven Frank
33 papers
Maria Cabanillas
32 papers
Michelle Williams
30 papers · 11 as a fellow
Amy Moreno
28 papers · 3 as a fellow

Grants

ImpACT: Improving Treatment Strategies for Anaplastic Thyroid Cancer Through Integration of Novel Therapies and Assessment of Tumor Response
National Cancer Institute · P01
Contact PI · $2.7M · University of Tx Md Anderson Can Ctr
2026–2031
InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery
National Cancer Institute · P01
PI · $4.8M · University of Tx Md Anderson Can Ctr
2025–2030
OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORship
National Cancer Institute · P01
PI · $7.1M · University of Tx Md Anderson Can Ctr
2024–2029
Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer
National Cancer Institute · R01
Contact PI · $3.3M · University of Tx Md Anderson Can Ctr
2022–2028

Clinical trials

Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2025–2032
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
Principal investigator · Recruiting · Phase 1
M.D. Anderson Cancer Center
2020–2027
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
Principal investigator · Recruiting · Phase 4
M.D. Anderson Cancer Center
2018–2031
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2017–2027